- Adults with obesity who received tirzepatide (Mounjaro) for 72 weeks following a 12-week intensive lifestyle intervention achieved a total mean weight loss greater than 24%, finds a new randomized double-blind placebo-controlled trial. The placebo group gained back 2.5% weight at 72 weeks. https://www.nature.com/articles/s41591-023-02597-w 146 comments science